Green Thumb Industries (GTBIF) Long-Term Investments (2018 - 2026)
Green Thumb Industries (GTBIF) reported Long-Term Investments of $32.7 million for Q1 2026, down 24.84% on a YoY basis from $43.5 million in Q1 2025, and little changed quarter-over-quarter from $32.7 million in Q4 2025.
Green Thumb Industries (GTBIF) Long-Term Investments (2018 - 2026) Analysis & Trends
Green Thumb Industries has reported Long-Term Investments for 9 years, with the latest figure at $32.7 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Investments fell 24.84% year-over-year to $32.7 million; the trailing twelve-month figure through Mar 2026 stood at $32.7 million (down 24.84% YoY), and the FY2025 full-year result was $32.7 million, down 24.92% from the prior year.
- Long-Term Investments for Q1 2026 stood at $32.7 million, roughly flat from $32.7 million in the prior quarter.
- The five-year high for Long-Term Investments was $90.7 million in Q1 2022, with the low at $32.7 million in Q1 2026.
- Historically, Long-Term Investments has averaged $61.3 million across 5 years, with a median of $61.4 million in 2024.
- Annual changes were most pronounced in 2022 — Long-Term Investments surged 212.16% — and 2024, when it plunged 32.29%.
- Green Thumb Industries' Long-Term Investments stood at $74.2 million in 2022, then declined by 13.22% to $64.4 million in 2023, then sank by 32.29% to $43.6 million in 2024, then decreased by 24.92% to $32.7 million in 2025, then fell by 0.17% to $32.7 million in 2026.
- The last three Long-Term Investments figures came in at $32.7 million (Q1 2026), $32.7 million (Q4 2025), and $43.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 1.32 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 26.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.90 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Green Thumb Industries | - | - | 143.65 Mn | 32.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.66 Mn |
| Dec 31, 2025 | 32.72 Mn |
| Sep 30, 2025 | 43.74 Mn |
| Jun 30, 2025 | 43.84 Mn |
| Mar 31, 2025 | 43.46 Mn |
| Dec 31, 2024 | 43.58 Mn |
| Sep 30, 2024 | 61.42 Mn |
| Jun 30, 2024 | 61.41 Mn |
| Mar 31, 2024 | 60.85 Mn |
| Dec 31, 2023 | 64.36 Mn |
| Sep 30, 2023 | 77.34 Mn |
| Jun 30, 2023 | 75.06 Mn |
| Mar 31, 2023 | 75.67 Mn |
| Dec 31, 2022 | 74.17 Mn |
| Sep 30, 2022 | 79.98 Mn |
| Jun 30, 2022 | 81.78 Mn |
| Mar 31, 2022 | 90.73 Mn |
| Dec 31, 2021 | 94.90 Mn |
| Sep 30, 2021 | 50.63 Mn |
| Jun 30, 2021 | 41.73 Mn |